SEC Filing Analysis: GE HealthCare Technologies Inc. (GEHC)

Executive Summary

• Trading Significance: Low
• Key Takeaway: General Counsel receives standard annual equity compensation grant (RSUs and Options) with 3-year vesting.
• Market Impact: Neutral - Routine compensation event with no signal regarding price sentiment.

Company Information

Field	Value
Company	GE HealthCare Technologies Inc.
Ticker Symbol	GEHC
CIK	0001932393
Industry	Medical Devices

Insider Information

Field	Value
Name	Jimenez Frank R
CIK	0001465175
Title/Position	GC & Corporate Secretary
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-03-02
Transaction Code	A (Grant/Award)
Security Type	Common Stock (RSUs) & Options
Shares Involved	10,915 (Stock) / 28,697 (Options)
Price Per Share	$0.00
Total Value	$0 (Compensation)
Shares Owned After	92,182
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0 (Grant)
% of Market Cap	0.00%
Shares Transacted	39,612 (Combined)
% of Shares Outstanding	0.0087%
Post-Transaction Ownership	92,182 shares (0.02% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market cap of $38.41 billion, this compensation grant is financially immaterial to the broader market.
• Ownership Concentration: The insider holds approximately 0.02% of the company, a standard level for a non-CEO executive in a large-cap firm.
• Dilution Impact: The issuance of ~39k new equity instruments against 455M shares outstanding results in negligible dilution (<0.01%).
• Transaction Significance: This is a "Code A" transaction, indicating a grant from the company rather than an open market purchase. It reflects remuneration policy rather than investment conviction.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Routine equity awards are expected operational expenses and do not typically drive stock price movement unless the size is unprecedented (which this is not).

Volume & Sentiment

• Expected Volume Impact: None.
• Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

• Vesting Schedule: Both the RSUs and Options vest ratably over three years (33%, 33%, 34%) starting September 2, 2027.
• Option Strike Price: The options have an exercise price of $80.16, likely the closing price on the date of the grant.